ES2002382A6 - Un procedimiento para la preparacion de una tableta farmaceutica para administracion oral - Google Patents

Un procedimiento para la preparacion de una tableta farmaceutica para administracion oral

Info

Publication number
ES2002382A6
ES2002382A6 ES8602263A ES8602263A ES2002382A6 ES 2002382 A6 ES2002382 A6 ES 2002382A6 ES 8602263 A ES8602263 A ES 8602263A ES 8602263 A ES8602263 A ES 8602263A ES 2002382 A6 ES2002382 A6 ES 2002382A6
Authority
ES
Spain
Prior art keywords
cefuroxime axetil
dragee
film coat
film
tablet core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8602263A
Other languages
English (en)
Inventor
David Deutsch
Jamshed Anwar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10585921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2002382(A6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES2002382A6 publication Critical patent/ES2002382A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE UNA TABLETA FARMACEUTICA PARA ADMINISTRACION ORAL, EN EL QUE SE COMPRIME UNA COMPOSICION QUE CONTIENE CANTIDADES EFICACES DE AXETIL-CEFUROXIMO Y UN AGENTE DE DESINTEGRACION, FORMANDO UN NUCLEO DE TABLETA QUE SE DESINTEGRA INMEDIATAMENTE DESPUES DE LA ROTURA DE SU RECUBRIMIENTO PELICULAR AL SOMETER LA TABLETA A UN ENSAYO DE ROTURA, Y SE REVISTE EL NUCLEO DE LA TABLETA CON UNA COMPOSICION FORMADORA DE PELICULA EN UNA SOLUCION ACUOSA O NO ACUOSA, PROPORCIONANDO UN RECUBRIMIENTO PELICULAR QUE SIRVE PARA ENMASCARAR EL SABOR AMARGO DEL AXETIL-CEFUROXIMO Y QUE TIENE UN TIEMPO DE ROTURA DE MENOS DE 40 SEGUNDOS. EXISTEN VIAS ALTERNATIVAS PARA PREPARAR ESTA TABLETA QUE SE DESCRIBEN EN LA MEMORIA. LAS TABLETAS OBTENIDAS SON ESPECIALMENTE UTILES COMO ANTIBIOTICOS POR SU GRAN ACTIVIDAD CONTRA UNA AMPLIA GAMA DE MICROORGANISMOS GRAM-POSITIVOS Y GRAM-NEGATIVOS.
ES8602263A 1985-09-30 1986-09-29 Un procedimiento para la preparacion de una tableta farmaceutica para administracion oral Expired ES2002382A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858524001A GB8524001D0 (en) 1985-09-30 1985-09-30 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES2002382A6 true ES2002382A6 (es) 1988-08-01

Family

ID=10585921

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8602263A Expired ES2002382A6 (es) 1985-09-30 1986-09-29 Un procedimiento para la preparacion de una tableta farmaceutica para administracion oral

Country Status (29)

Country Link
US (1) US4897270A (es)
EP (1) EP0223365B1 (es)
JP (1) JP2661662B2 (es)
KR (1) KR940000233B1 (es)
AT (1) AT393081B (es)
AU (1) AU594082B2 (es)
BE (1) BE905518A (es)
CA (1) CA1282331C (es)
CH (1) CH672736A5 (es)
CY (1) CY1563A (es)
DE (2) DE3677710D1 (es)
DK (1) DK175349B1 (es)
ES (1) ES2002382A6 (es)
FR (1) FR2591597B1 (es)
GB (2) GB8524001D0 (es)
GR (1) GR862464B (es)
HK (1) HK84990A (es)
IE (1) IE59089B1 (es)
IL (1) IL80165A (es)
IT (1) IT1196644B (es)
LU (1) LU86613A1 (es)
NL (1) NL8602466A (es)
NO (1) NO173636C (es)
NZ (1) NZ217720A (es)
PH (1) PH25702A (es)
PT (1) PT83459B (es)
SA (1) SA91120189B1 (es)
SE (1) SE8604114L (es)
ZA (1) ZA867318B (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
AT393955B (de) * 1990-03-30 1992-01-10 Martin Dr Leixnering Einrichtung zur nachbehandlung frischer beugesehnenverletzungen
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
GB2256587A (en) * 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (es) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
AU3277899A (en) * 1998-03-03 1999-09-20 Dae Woong Chemical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
IN191239B (es) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
PT1194124E (pt) * 1999-06-11 2004-02-27 Ranbaxy Lab Ltd Composicoes de sabor mascarado
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
AU2001230490A1 (en) * 2000-12-01 2002-06-11 Arun Shriniwas Gosavi Pharmaceutical formulation
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
ES2201932B2 (es) * 2001-11-23 2005-03-16 Glaxo Group Limited Composicion farmaceutica.
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
KR100523082B1 (ko) * 2002-09-11 2005-10-20 (주)다산메디켐 쓴 맛이 은폐된 세푸록심악세틸 제제의 제약조성물 및 그의 제조방법
ATE468847T1 (de) * 2002-12-31 2010-06-15 Boehringer Ingelheim Int Filmtablette mit extrakt aus roten weinblättern
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
US20050079213A1 (en) * 2003-06-06 2005-04-14 Unilab Pharmatech Ltd Pharmaceutical compositions
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
US20050084540A1 (en) * 2003-10-17 2005-04-21 Indranil Nandi Taste masking antibiotic composition
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
US20090175952A1 (en) * 2004-01-09 2009-07-09 Jong Soo Woo Cefuroxime axetil granule and process for the preparation thereof
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
JP2007523110A (ja) * 2004-02-19 2007-08-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 赤ブドウ葉の抽出物および抗炎症剤を含む、慢性静脈疾患を治療するための組成物
EP1737433B1 (en) * 2004-04-12 2007-11-14 Pfizer Products Incorporated Taste-masked drugs in rupturing multiparticulates
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
EP2091519B1 (en) * 2006-11-30 2015-06-24 Bend Research, Inc Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US8529914B2 (en) * 2010-06-28 2013-09-10 Richard C. Fuisz Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
CN104136004B (zh) 2012-02-22 2018-03-06 达切斯内公司 多西拉敏和吡哆醇和/或其代谢物或盐的制剂
WO2013151516A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Film tablet formulations comprising cefuroxime axetil and clavulanic acid
CN105338981B (zh) 2013-04-25 2017-10-13 杏林制药株式会社 固体药用组合物
ES2768651T3 (es) 2013-04-25 2020-06-23 Kyorin Seiyaku Kk Composición farmacéutica sólida
ES2670619T3 (es) 2013-07-22 2018-05-31 Duchesnay Inc. Composición para la gestión de náuseas y vómitos
JP6018334B2 (ja) 2014-10-23 2016-11-02 杏林製薬株式会社 固形医薬組成物
US20250009725A1 (en) 2021-11-10 2025-01-09 Daiichi Sankyo Company, Limited Pharmaceutical composition having excellent dissolution properties
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3372015A (en) * 1963-11-15 1968-03-05 Pittsburgh Plate Glass Co Method of and apparatus for equalizing the cooling of a glass sheet supported on a bending mold
US3383236A (en) * 1964-04-17 1968-05-14 Merck & Co Inc Continuous pharmaceutical film coating process
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3256111A (en) * 1964-12-04 1966-06-14 Abbott Lab Method for coating tablets
US3477864A (en) * 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3981984A (en) * 1968-04-01 1976-09-21 Colorcon Incorporated Color film coating of tablets and the like
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
JPS52151717A (en) * 1976-06-09 1977-12-16 Shionogi & Co Ltd Sugar coating on solid preparations
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4470980A (en) * 1980-03-07 1984-09-11 Interx Research Corp. Method of increasing oral absorption of β-lactam antibiotics
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
ATE67769T1 (de) * 1983-01-25 1991-10-15 Ciba Geigy Ag Neue peptidderivate.
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8324152D0 (en) * 1983-09-09 1983-10-12 Glaxo Group Ltd Chemical process
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
JPS60169416A (ja) * 1984-02-14 1985-09-02 Taisho Pharmaceut Co Ltd 素錠の表面処理方法
US4616008A (en) * 1984-05-02 1986-10-07 Takeda Chemical Industries, Ltd. Antibacterial solid composition for oral administration
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.

Also Published As

Publication number Publication date
DK462486A (da) 1987-03-31
AU6323286A (en) 1987-04-02
PT83459B (pt) 1989-05-12
GR862464B (en) 1987-02-02
NZ217720A (en) 1988-07-28
KR870002832A (ko) 1987-04-13
SE8604114L (sv) 1987-03-31
DE3677710D1 (de) 1991-04-04
CA1282331C (en) 1991-04-02
GB8524001D0 (en) 1985-11-06
NO173636B (no) 1993-10-04
IE59089B1 (en) 1994-01-12
AU594082B2 (en) 1990-03-01
LU86613A1 (fr) 1988-04-05
JPS62123118A (ja) 1987-06-04
SA91120189B1 (ar) 2001-10-07
SE8604114D0 (sv) 1986-09-29
CY1563A (en) 1991-05-17
AT393081B (de) 1991-08-12
DE3633292A1 (de) 1987-04-09
FR2591597A1 (fr) 1987-06-19
PH25702A (en) 1991-09-18
ATA260986A (de) 1991-01-15
NO863863L (no) 1987-03-31
FR2591597B1 (fr) 1989-06-02
DK462486D0 (da) 1986-09-29
GB8623340D0 (en) 1986-11-05
IL80165A (en) 1991-06-10
IL80165A0 (en) 1986-12-31
IE862564L (en) 1987-03-30
IT1196644B (it) 1988-11-16
IT8648492A0 (it) 1986-09-29
NO173636C (no) 1994-01-12
DK175349B1 (da) 2004-09-06
GB2181052A (en) 1987-04-15
NL8602466A (nl) 1987-04-16
EP0223365A3 (en) 1988-06-08
BE905518A (fr) 1987-03-30
GB2181052B (en) 1989-10-18
ZA867318B (en) 1987-05-27
PT83459A (en) 1986-10-01
JP2661662B2 (ja) 1997-10-08
EP0223365A2 (en) 1987-05-27
EP0223365B1 (en) 1991-02-27
KR940000233B1 (ko) 1994-01-12
US4897270A (en) 1990-01-30
HK84990A (en) 1990-10-25
NO863863D0 (no) 1986-09-29
CH672736A5 (es) 1989-12-29

Similar Documents

Publication Publication Date Title
HK84990A (en) Film coated cefuroxime axetil tablets
CA2061520A1 (en) Delivery system for enhanced onset and increased potency
AP8900133A0 (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
HU900394D0 (en) Process for producing a new compound of medical effect and pharmaceutical preparatives containing it
ITBO920295A1 (it) Metodo e dispositivo per il dosaggio di un prodotto farmaceutico all'interno di capsule
IL104192A0 (en) Pharmaceutical dosage forms having prolonged release rate of active ingredient
AU552547B2 (en) Nonapeptide for treatment of drug withdrawal symptoms
JPS57142251A (en) Production of drug capsule
AU8336982A (en) Nasal administration of b-blockers and dosage forms therefor
GB1380171A (en) Medicinal tablets
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
EP0282156A3 (en) Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
AU683229B2 (en) Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it
JPS57114508A (en) Pharmaceutical medicine for use of choline- action suppressive drug
AU3019389A (en) 6-oxo-4,5-dihydro-pyridazine derivatives, a process for their preparation and medicaments containing these compounds
IL71470A (en) Pharmaceutical forms of sulpiride suitable for oral administration and their preparation
UA13788C2 (uk) Адаптогеhhий препарат та спосіб його одержаhhя
GB1292496A (en) Dosage units of contraceptive preparations for human use
ZW20982A1 (en) Aminooxazolyl compounds processes for their manufacture pharmaceutical preparations containing these compounds and the use of the latter
GB950162A (en) Medicines for the treatment of hepatic disorders
JO1718B1 (en) Solid dosage form of Muclant drug and its manufacturing processes
AU474505B2 (en) Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment
JPS57135793A (en) Manufacture of match head drug
ZA825047B (en) Aminotriazolyl compounds,processes for the manufacture thereof,pharmaceutical preparations containing such compounds,and the use of the latter

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-09-29

GD1A Contractual licences

Effective date: 20040913

FD1A Patent lapsed

Effective date: 20060930